YOUNG KWON - 06 Mar 2023 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Young Kwon, by Brian Lenz as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
06 Mar 2023
Net transactions value
$0
Form type
4
Filing time
08 Mar 2023, 20:30:33 UTC
Previous filing
09 Mar 2022
Next filing
24 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Award $0 +25,815 +11% $0.000000 252,401 06 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Employee Stock Option (right to buy) Award $0 +51,630 $0.000000 51,630 06 Mar 2023 Common Stock 51,630 $3.35 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.
F2 Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 213,293 shares of common stock owned by the reporting person.
F3 The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.